PAPER Ghosh P, Kundu A, Ganguly D

From experimental studies to computational approaches: recent trends in designing novel therapeutics for amyloidogenesis.

J Mater Chem B. 2025 Jan 15;13(3):858-881. PubMed.

PAPER Chen LX, Zhang MD, Xu HF, Ye HQ, Chen DF, Wang PS, Bao ZW, Zou SM, Lv YT, Wu ZY, Li HF

Single-Nucleus RNA Sequencing Reveals the Spatiotemporal Dynamics of Disease-Associated Microglia in Amyotrophic Lateral Sclerosis.

Research (Wash D C). 2024;7:0548. Epub 2024 Dec 11 PubMed.

PAPER Maleki L, Mohammadian F, Panahishokouh M, Mohebbi N

A randomized, double-blind, placebo-controlled clinical trial to evaluate pregabalin efficacy in the treatment of behavioral and psychological symptoms of dementia in patients with Alzheimer's disease.

Front Neurosci. 2024;18:1460325. Epub 2024 Nov 27 PubMed.

PAPER Xiao Y, Fan Y, Feng Z

A meta-analysis of the efficacy of physical exercise interventions on activities of daily living in patients with Alzheimer's disease.

Front Public Health. 2024;12:1485807. Epub 2024 Nov 27 PubMed.

PAPER Wang X, Shi Y

Adaptive Subtype and Stage Inference for Alzheimer's Disease.

Med Image Comput Comput Assist Interv. 2024 Oct;15003:46-55. Epub 2024 Oct 3 PubMed.

PAPER Llorente-Saguer I, Oxtoby NP

A data-driven framework for biomarker discovery applied to optimizing modern clinical and preclinical trials on Alzheimer's disease.

Brain Commun. 2024;6(6):fcae438. Epub 2024 Dec 9 PubMed.

PAPER An X, He J, Bi B, Wu G, Xu J, Yu W, Ren Z

The role of astrocytes in Alzheimer's disease: a bibliometric analysis.

Front Aging Neurosci. 2024;16:1481748. Epub 2024 Nov 27 PubMed.

PAPER Heming M, Börsch AL, Melnik S, Gmahl N, Müller-Miny L, Dambietz C, Fisch L, Kühnel T, Brix TJ, Janssen A, Schumann E, Gross CC, Varghese J, Hahn T, Wiendl H, Meyer Zu Hörste G

Atlas of Cerebrospinal Fluid Immune Cells Across Neurological Diseases.

Ann Neurol. 2024 Dec 12; Epub 2024 Dec 12 PubMed.

PAPER Rudolph J, Rueckel J, Döpfert J, Ling WX, Opalka J, Brem C, Hesse N, Ingenerf M, Koliogiannis V, Solyanik O, Hoppe BF, Zimmermann H, Flatz W, Forbrig R, Patzig M, Rauchmann BS, Perneczky R, Peters O, Priller J, Schneider A, Fliessbach K, Hermann A, Wiltfang J, Jessen F, Düzel E, Buerger K, Teipel S, Laske C, Synofzik M, Spottke A, Ewers M, Dechent P, Haynes JD, Levin J, Liebig T, Ricke J, Ingrisch M, Stoecklein S

Artificial intelligence-based rapid brain volumetry substantially improves differential diagnosis in dementia.

Alzheimers Dement (Amst). 2024;16(4):e70037. Epub 2024 Dec 11 PubMed.

PAPER Zhang N, Nao J, Dong X

Efficacy and Safety of Natural Apigenin Treatment for Alzheimer's Disease: Focus on In vivo Research Advancements.

Curr Neuropharmacol. 2024 Dec 11; Epub 2024 Dec 11 PubMed.

PAPER Maiese K

Wnt Signaling, Musculoskeletal Disease, and the Onset of Dementia and Alzheimer's Disease.

Curr Neurovasc Res. 2024 Dec 11; Epub 2024 Dec 11 PubMed.

PAPER Starkie DO, Arber C, Baker T, Lightwood DJ, Wray S

Antibody-mediated degradation of 4R-tau restores mitochondrial membrane polarization in human induced pluripotent stem cell-derived neurons with the MAPT 10+16 mutation.

MAbs. 2024;16(1):2436102. Epub 2024 Dec 12 PubMed.

PAPER Muolokwu CE, Gothwal A, Kanekiyo T, Singh J

Synthesis and Characterization of Transferrin and Cell-Penetrating Peptide-Functionalized Liposomal Nanoparticles to Deliver Plasmid ApoE2 In Vitro and In Vivo in Mice.

Mol Pharm. 2025 Jan 6;22(1):229-241. Epub 2024 Dec 12 PubMed.

PAPER Wang W, Zhang J, Li C

Randomized controlled trial of bushen yinao pill combined with conventional therapy on intestinal flora imbalance and cognitive function improvement in older patients with Alzheimer's disease.

Int J Psychiatry Med. 2024 Dec 12;:912174241290962. Epub 2024 Dec 12 PubMed.

PAPER Eng S, Aifuwa E, Frishman WH, Aronow WS

Cardiovascular Effect of Drugs Used to Treat Alzheimer's Disease.

Cardiol Rev. 2024 Dec 12; Epub 2024 Dec 12 PubMed.